Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Survival of Peripheral T-Cell Lymphomas (PTCLs) Patients Following Relapse: Spectrum of Disease and Rare Long-Term Survivors

Vivien Mak, MBBS FHKAM, Joseph M. Connors, MD, Richard Klasa, MD, Laurie H. Sehn, MD, MPH, Diego Villa, MD, MPH, Tamara Shenkier, MD, Mukesh Chhanabhai, MD, Randy D. Gascoyne, MD, Kerry J. Savage, MD MSc

Blood (2011) 118 (21): 96.

https://doi.org/10.1182/blood.V118.21.96.96

Published: 2011

Journal Articles

The Prognosis of Limited Stage Peripheral T-Cell Lymphoma (PTCL): A Population-Based Analysis and Comparison to Diffuse Large B-Cell Lymphoma (DLBCL)

Kerry Joanne Savage, MD, MSc, Hilary M O'Leary, MBBChBAO, MRCPI, MRCPath, Joseph M Connors, MD, Mukesh Chhanabhai, MD, Belinda Campbell, MD, Laurie H Sehn, MD, MPH, Randy D. Gascoyne, MD, R. Gregory Bociek, MD, James O. Armitage, MD, Dennis D. Weisenburger, MD, Julie M. Vose, Martin Bast, BS, Philip Bierman, MD

Blood (2010) 116 (21): 4129.

https://doi.org/10.1182/blood.V116.21.4129.4129

Published: 2010

Journal Articles

Both Discordant and Concordant Bone Marrow (BM) Involvement Predict for a Poorer Outcome Independent of the IPI in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP.

Laurie H. Sehn, MD, MPH, Mukesh Chhanabhai, MD, Suman Singh, Wayne Saville, MD, Dan Matso, PhD, John J. Spinelli, PhD, Joseph M. Connors, MD, Randy D. Gascoyne, MD

Blood (2007) 110 (11): 1559.

https://doi.org/10.1182/blood.V110.11.1559.1559

Published: 2007

Journal Articles

Outcome in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CHOP-R Can Be Predicted by Stage and Serum Lactate Dehydrogenase (LDH) Level.

Laurie H. Sehn, MD, MPH, Mukesh Chhanabhai, MD, Karamjit Gill, MD, Paul Hoskins, MD, Richard Klasa, MD, Kerry J. Savage, MD, Tamara Shenkier, MD, Judy Sutherland, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD

Blood (2006) 108 (11): 2739.

https://doi.org/10.1182/blood.V108.11.2739.2739

Published: 2006

Journal Articles

Evaluation of a New Prognostic Index for Peripheral T-Cell Lymphoma, Unspecified (PTCL-US).

Heather L. McArthur, MD, Mukesh Chhanabhai, MD, Gascoyne D. Randy, MD, Connors M. Joseph, MD, Savage J. Kerry, MD

Blood (2005) 106 (11): 2812.

https://doi.org/10.1182/blood.V106.11.2812.2812

Published: 2005

Journal Articles

Survival of Limited Stage Peripheral T-Cell Lymphoma Is Similar To Diffuse Large B-Cell Lymphoma.

Kerry J. Savage, MD, Mukesh Chhanabhai, MD, Nicholas Voss, MD, Shenkier Tamara, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD

Blood (2005) 106 (11): 2817.

https://doi.org/10.1182/blood.V106.11.2817.2817

Published: 2005

Journal Articles

Revised International Prognostic Index (R-IPI) Is a Better Predictor of Outcome Than the Standard IPI for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab and CHOP (R-CHOP).

Laurie H. Sehn, MD, MPH, Mukesh Chhanabhai, MD, Catherine Fitzgerald, MD, Karamjit Gill, MD, Paul Hoskins, MD, Richard Klasa, MD, Kerry Savage, MD, Tamara Shenkier, MD, Judy Sutherland, MD, Kenneth Wilson, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD

Blood (2005) 106 (11): 492.

https://doi.org/10.1182/blood.V106.11.492.492

Published: 2005

Journal Articles

Transformed Lymphoma: Incidence and Long-Term Outcome.

Abdulwahab J. Al-Tourah, MB, BCh, FRCPC, Mukesh Chhanabhai, MD, FRCPC, Paul J. Hoskins, MD, FRCPC, Richard J. Klasa, MD, FRCPC, Kerry J. Savage, MD, FRCPC, Laruie H. Sehn, MD, FRCPC, Tamara N. Shenkier, MD, FRCPC, Randy D. Gascoyne, MD, FRCPC, Joseph M. Connors, MD, FRCPC

Blood (2004) 104 (11): 3253.

https://doi.org/10.1182/blood.V104.11.3253.3253

Published: 2004

NARROW

Survival of Peripheral T-Cell Lymphomas (PTCLs) Patients Following Relapse: Spectrum of Disease and Rare Long-Term Survivors

The Prognosis of Limited Stage Peripheral T-Cell Lymphoma (PTCL): A Population-Based Analysis and Comparison to Diffuse Large B-Cell Lymphoma (DLBCL)

Both Discordant and Concordant Bone Marrow (BM) Involvement Predict for a Poorer Outcome Independent of the IPI in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP.

Outcome in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CHOP-R Can Be Predicted by Stage and Serum Lactate Dehydrogenase (LDH) Level.

Evaluation of a New Prognostic Index for Peripheral T-Cell Lymphoma, Unspecified (PTCL-US).

Survival of Limited Stage Peripheral T-Cell Lymphoma Is Similar To Diffuse Large B-Cell Lymphoma.

Revised International Prognostic Index (R-IPI) Is a Better Predictor of Outcome Than the Standard IPI for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab and CHOP (R-CHOP).

Transformed Lymphoma: Incidence and Long-Term Outcome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only